Objectives: To review our surgical experience of primary infected abdominal aortic aneurysms, with the aim of assessing the safety and durability of in situ prosthetic replacement. Design: Retrospective study in a university hospital. Materials and Methods: Thirty-four patients who underwent surgery for primary infected abdominal aortic aneurysms over the past 18 years were reviewed. Operative details and outcomes were recorded for analysis. Results: There were six suprarenal and 28 infrarenal infections. Salmonellae (18 patients) were the most common pathogens. Thirty patients underwent in situ prosthetic replacement, two underwent extra-anatomic bypass and two underwent endovascular repair. The surgical mortality for overall patients was 18%, and for patients reconstructed in situ, 17%. Among the 30 patients reconstructed in situ, four patients who underwent concomitant gastrointestinal procedures (e.g., repair of the duodenal defect) died. By contrast, 25 of 26 patients without gastrointestinal involvement survived surgery. After a median follow-up period of 58 months, two discharged patients who underwent in situ reconstruction died of late graft infection.
Introduction
Infected aortic aneurysms are rare diseases that present challenging scenarios to clinicians. Affected patients usually present with non-specific manifestations, and a delay in diagnosis until severe sepsis or aneurysm rupture occurs is not uncommon. 1e9 Despite advances in medical and surgical treatment, reported morbidity and mortality remain high. Large series and literature reviews have documented hospital mortality rates of 16e42%, and the vast majority of deaths are attributed to sepsis or rupture. 1e13 Among the patients who survive until discharge, a significant proportion may develop recurrent infection. 4e6,13e15 A combination of aneurysm resection and effective antibiotic therapy is believed to be the mainstay of treatment for infected aortic aneurysms. Distal perfusion can be restored by either in situ reconstruction or extraanatomic bypass. Traditionally, the surgical principle consists of aortic ligation, excision of all infected tissue and extra-anatomic bypass through a remote non-infected field. 6, 10, 14, 17 This approach is substantially flawed by inferior patency, the necessity for future reconstruction and, most importantly, the continuing risk of stump blowout. 4, 10, 14, 17, 18 Over the past two decades, in situ reconstruction has gradually become the standard procedure, based on promising results repeatedly reported in surgical literature. 6,11,14,18e20 However, in situ reconstruction is recommended only in patients with controlled infection, minimal purulence or elective surgery after prolonged antibiotic administration. 1, 2, 5, 6, 17, 21 Graft contamination remains a major concern when surgeons select in situ reconstruction.
Clinically, infected aneurysms in the abdominal aorta differ from their thoracic counterparts in many respects, including their anatomy and associated surgical considerations. 2, 22 Due to their infectious nature, infected abdominal aortic aneurysms are occasionally complicated by the involvement of anatomically adjacent structures, for example, the psoas muscles, vertebral bodies, inferior vena cava and gastrointestinal tract. 1e7, 10, 12, 13 Reciprocal infections between infected aneurysms and contiguous structures represent extensive periaortic infections that not only require additional debridement and repair but also potentially increase the risk of graft infection. Whether in situ reconstruction can be performed safely in every patient with an infected abdominal aortic aneurysm, especially in the presence of extensive infection, remains uncertain. This study reviews our experiences with a series of 34 patients undergoing surgery for primary infected abdominal aortic aneurysms, with the aim of assessing the safety and durability of in situ prosthetic replacement.
Patients and Methods
We searched our vascular surgery database to identify 34 consecutive patients with primary infected aneurysms in the abdominal aorta between July 1993 and March 2010. All patients (1) presented preoperatively with clinical symptoms/signs of infection (fever, pain, and leucocytosis), (2) had typical findings (periaortic inflammation, rapid aneurysm progression on sequential CT and periaortic gas) in contrast-enhanced computed tomography (CT) and (3) had either a positive preoperative blood culture or intraoperative tissue culture or both. In patients undergoing open repair, the diagnosis was further confirmed with surgical findings (inflammation and purulence). Culturenegative patients were not included in this series. Patients with infected aneurysms secondary to prosthetic graft infections were excluded from this study.
For all patients, the following data were recorded: age, gender, clinical presentation, underlying diseases, anatomic location of the aneurysm, results of blood and tissue cultures, operative findings and techniques, duration of antibiotic therapy and early and late outcomes. This study was approved by the local institutional review board.
Statistical analysis
Comparisons between groups were performed using the c 2 test or Fisher's exact test. Statistical analyses were performed using the Statistical Package for the Social Sciences for Windows, Version 12.0 (SPSS, Chicago, IL, USA), and P < 0.05 was considered significant.
Results

Patients, clinical presentations and pathogens
During the 18-year period of this study, 28 men and six women with infected abdominal aortic aneurysms underwent surgery in our hospital. The median patient age was 69 (range, 37e80) years. All of the patients were symptomatic. Patient characteristics are summarised in Table 1 . Culture results were obtained from blood only (13 patients), tissue only (7) or both (14) . Salmonellae (18 patients) were the most common pathogens. Other causative pathogens are detailed in Table 2 .
CT findings
Sequential CT studies of the six patients who were initially reluctant to undergo surgery revealed radiologic evidence of disease progression. At the latest preoperative CT imaging, saccular-type aneurysms were present in 26 patients (77%), while periaortic soft-tissue mass with a preexisting fusiform aneurysm was present in one patient (3%). Infection extending to neighbouring retroperitoneal structures, including psoas muscles abscess or spondylodiscitis ( Fig. 1 ), was noted in eight patients (25%). Gas collection and massive perianeurysmal haemorrhage were each present in five patients (16%).
Perioperative management and operative details
Once the diagnosis of an infected aneurysm was established, broad-spectrum intravenous antibiotics (e.g., third-generation cephalosporins) were administered and surgery was scheduled as early as possible. Emergency surgery was conducted for patients presenting with shock or persistent pain.
Thirty-two patients underwent open surgery. At surgery, the aneurysm, necrotic periarterial tissue, retroperitoneal haematoma and purulent material were radically removed after vascular control was achieved. Rupture with surrounding haematoma was present in 17 patients (53%). Eight patients required additional debridement of psoas muscle abscess and/or lumbar sequestrectomy based on the CT and operative findings. With regard to the management of distal reperfusion, all except two patients with infrarenal infection underwent in situ reconstruction. For the two patients who were reconstructed extra-anatomically, an axillo-bifemoral bypass was conducted following emergency aortic ligation to control active haemorrhage. Collectively, in situ reconstruction using tube or bifurcated Dacron grafts (Hemashield, Boston Scientific/Meadox Medicals, Oakland, NJ, USA) was performed in 30 patients and extra-anatomic bypass was performed in two patients. The Dacron grafts were not soaked in rifampin or disinfectant solutions. Cryopreserved allografts were not used due to lack of availability. Early in this study, we prepared a flap-like omentum with a preserved blood supply to confer protection against graft infection if purulent material was present before debridement. In the past 6 years, omental flap transposition has been used as a routine adjunct procedure whenever feasible. Overall, omental flaps were used in 21 patients (66%). Four of the patients reconstructed in situ underwent concomitant gastrointestinal procedures ( Table 3 ). The fragile duodenal defects in these patients were repaired with interrupted silk sutures and omental flap transposition was used to cover the defects. Among the four patients undergoing concomitant gastrointestinal procedures, three patients also required debridement of psoas muscle abscess.
Endovascular repair using Zenith modular stent grafts (Cook, Bloomington, IN, USA) was performed in two patients, whose infected aneurysms were located in the infrarenal aorta. The pathogen (serogroup D Salmonella) of the two patients was preoperatively identified by blood culture and both patients responded excellently to initial antibiotics. No drainage or additional procedures were performed.
Postoperatively, pathogen-specific antibiotics were chosen on the basis of the culture results. The duration of intravenous antibiotic administration, usually 4e8 weeks, was based on clinical response, laboratory data and recommendations from infectious disease specialists. Oral antibiotics were given following discharge, usually for 2e6 months. None of the patients received lifelong antibiotics.
Early (surgical) outcomes
The overall surgical mortality rate was 18% (6/34). The mortality rates were not significantly different among patients with suprarenal (1/6, 17%) versus infrarenal (5/28, 18%; P > 0.999) abdominal aortic aneurysms.
Five (17%) of the 30 patients who underwent in situ reconstruction died after surgery. The only surgical mortality among the six patients with suprarenal infection was a 76-year-old woman with infection caused by Staphylococcus aureus. This patient developed a sudden anastomotic disruption after persistent methicillin-resistant Staphylococcus aureus septicaemia and expired during reoperation due to uncontrolled bleeding. Of the 24 patients who underwent in situ reconstruction for infrarenal infection, four patients who underwent concomitant gastrointestinal procedures died (Table 3) . By contrast, 20 patients without gastrointestinal involvement survived surgery. Collectively, for patients reconstructed in situ, 25 of 26 patients (96%) without gastrointestinal involvement survived surgery. The major surgical complications observed in survivors included prolonged adhesive ileus requiring enterolysis in one patient and respiratory failure necessitating prolonged ventilatory support in another patient. There was no perioperative intestinal ischaemia, limb loss or dialysis-requiring acute renal failure. Of the two patients who underwent extra-anatomic bypass, one patient died of multiple organ failure, secondary to intraoperative bleeding and ongoing sepsis. The other patient Figure 1 Contrast-enhanced CT scan showed an infected infrarenal aortic aneurysm with coexistence of bilateral psoas muscle abscess (arrows) and vertebral body destruction (arrowheads). 
Late outcomes
There were 28 discharged survivors, including 25 patients with in situ reconstruction. The median follow-up for discharged patients was 58 (range, 4e183) months. Follow-up was completed for 32 patients (94%). Of the eight patients who underwent debridement of psoas muscle abscess and/ or lumbar sequestrectomy, five patients without gastrointestinal involvement survived to discharge. All five patients were free from graft infection after a median follow-up of 49 (range, 12e141) months. During the follow-up period, two discharged patients died of late graft infection. One 73-year-old man initially had an infrarenal infection caused by Enterobacter aerogenes. This patient died of massive gastrointestinal bleeding, possibly caused by a secondary aortoenteric fistula, at 12 months. One 72-year-old man initially had an infected infrarenal aortic aneurysm caused by Salmonella serogroup B. This patient developed a secondary aortoduodenal fistula through the reimplantation site of the inferior mesenteric artery 25 months after surgery. Immediately after reoperation, he died of depressed cardiac output associated with underlying hypertrophic obstructive cardiomyopathy. Two patients treated with endovascular repair have been well for 8 and 24 months postoperatively. Follow-up CT of both patients confirmed regression of the infected aneurysms without signs of endoleak or stent-graft migration. Other discharged patients, including the survivor who underwent extraanatomic bypass, did not experience any aneurysmrelated events during the follow-up period.
In summary, the rate of incidence of late aneurysmrelated mortality among discharged survivors undergoing in situ reconstruction was 8% (2/25). Fig. 2 summarises the surgical procedures and outcomes of the 34 patients in this study. The overall aneurysm-related mortality rate for patients in this study was 24% (8/34), and for patients reconstructed in situ, 23% (7/30). Among the 30 patients who underwent in situ reconstruction, infection complicated by gastrointestinal involvement was associated with higher incidences of surgical mortality (100 vs. 4%; P Z 0.0002) and overall aneurysm-related mortality (100 vs. 12%, P Z 0.001) than infection without gastrointestinal involvement.
Discussion
It is widely accepted that, for suprarenal infection, in situ reconstruction is the most feasible and preferred surgical option due to the necessity for visceral revascularisation in this difficult anatomic region. 1e3, 23 For patients with infrarenal infection, controversy concerning the management of distal revascularisation still exists. Conducting an impartial clinical comparison between in situ reconstruction and extra-anatomic bypass is almost impossible due to the rarity of infected aortic aneurysms, prior knowledge of possible risks following the two procedures and potential bias in patient selection. Upon recent studies reported in the surgical literature, 1, 2, 5, 6, 13, 19, 21 most surgeons performed in situ reconstruction only under conditions of controlled infection or limited contamination. This reflects general concerns regarding graft infection following in situ reconstruction. Indeed, although a significant incidence of major procedure-specific complications (e.g., aortic stump disruption and limb loss) has been described, some surgeons (Table 4 ) still prefer extra-anatomic bypass because revascularisation is performed remotely to the infection site, attenuating the risk of graft contamination. 8, 10, 17, 18, 21 The ideal choice between in situ reconstruction and extra-anatomic bypass depends on the experience of the surgeon, the condition of the patient and, most importantly, whether the operative field after aggressive debridement is sterile enough for in situ reconstruction. To date, a consensus regarding when to use or not to use in situ reconstruction has not been unequivocally established. Our experience with almost generalised adoption of in situ prosthetic replacement may help to clarify this unresolved issue.
Our study demonstrates the clinical impact of gastrointestinal involvement in patients with infected abdominal aortic aneurysms. The requirement of concomitant gastrointestinal procedures was associated with surgical In Situ Reconstruction for Infected Aneurysms mortality and overall aneurysm-related mortality in patients who underwent in situ prosthetic replacement. In our experience, patients with duodenojejunal invasion tended to present with shock and rupture simultaneously, both of which may further aggravate disease severity. Infection in these patients disseminated extensively into the peritoneal cavity, far more serious than limited periaortic contamination with a sterile peritoneal cavity. In addition, repair of a large duodenal defect surrounded by unhealthy inflammatory tissue rather than a well-formed fistula is technically challenging, potentially leading to bowel leakage, persistent intra-abdominal sepsis and graft infection. 14, 24, 25 These findings suggest that gastrointestinal involvement most likely signifies a very advanced stage of the infected aneurysms.
Due to the limited number of cases reported in the literature, the ideal management for infected aneurysms complicated by gastrointestinal involvement remains undetermined. Even with aggressive debridement, our experience with in situ prosthetic replacement in such a hostile operative field was dismal. Accordingly, we emphasise extreme caution when considering this technique in the presence of gastrointestinal involvement. Sufficient peritoneal drainage combined with extraanatomic bypass or in situ reconstruction using a conduit that has greater bacterial resistance (e.g., a cryopreserved arterial allograft) might improve the surgical outcomes in these difficult cases. 20, 25, 26 By contrast, with aggressive debridement and prolonged use of intravenous antibiotics, in situ prosthetic replacement provided favourable outcomes in patients without concomitant gastrointestinal procedures. Among 26 patients without gastrointestinal involvement, only one with suprarenal infection died after surgery. Among 20 patients who underwent in situ reconstruction for infrarenal infection, there was no surgical mortality. In this study, we have continued the use of traditional Dacron grafts in conjunction with several technical adjuncts. Omental flaps help to separate the grafts and anastomoses from the contaminated surgical plane as well as to fill dead space. 2, 4, 14, 19 In addition, the highly-vascularised tissue flap also acts as a protective dressing containing systemic antibiotics. Antibiotic-impregnated fibrin glue and local administration of antibiotics may also be useful for this purpose. 16, 20 Since a late graft infection associated with the reimplantation site of the inferior mesenteric artery occurred, we relocated the distal anastomoses of bifurcated grafts into the groin area to reduce the number of intra-field anastomoses. The grafts were rerouted to lie in a track outside the original contaminated plane. These technical modifications may help to prevent prosthetic grafts from direct contact with residual purulence and reduce the occurrence of graft infection. As shown in Table  4 , a variety of graft modifications and conduits (e.g., antibiotic-soaked prostheses) have been introduced for in situ reconstruction in the setting of primary aortoiliac infection. 2, 11 These grafts provide alternative options with superior resistance to bacteria. 11, 27, 28 Previous studies have described the impact of coexisting psoas muscle abscess 5 or infective spondylodiscitis 29 on patients with infected aneurysms. These conditions represent extensive retroperitoneal infection and were regarded as relative contraindications to in situ reconstruction. Despite the small number of cases, our experience with in situ reconstruction in these cases was promising. Adequate debridement following a detailed and thorough preoperative assessment using CT imaging, which accurately illustrates the infected aneurysm and the extent of retroperitoneal involvement, makes in situ prosthetic replacement a potential option in the presence of psoas muscle abscess or infective spondylodiscitis. 4, 10, 30 More recently, the success of endovascular repair as a less invasive alternative for the treatment of aortic aneurysms has inspired surgeons to extend this approach to infected pathologies. 9,22,31e33 Although a systematic review based on sporadic cases yielded a 30-day survival rate of 89.6%, 32 a suspicion of publication bias has emerged. 33 Furthermore, late aneurysm-related mortalities and complications are frequent, mainly associated with inadequate control of infection. Therefore, an excellent response to preoperative antibiotics is necessary, as antibiotic treatment is the major, if not the only, method for eradicating infection. 32, 33 Currently, the safety and durability of endovascular repair for the treatment of infected aneurysms, especially for patients with an extensive periaortic infection, remain uncertain. In this study, we observed two cases successfully managed by endovascular repair.
Because only a few studies have established results for late aneurysm-related events, no consensus has been reached regarding the post-discharge duration of oral antibiotic therapy. 1e5, 14, 17, 21, 34 Without lifelong antibiotics, the rate of incidence of late aneurysm-related mortality was 8% among survivors who underwent in situ reconstruction. This result is not inferior to those from studies of patients on lifelong antibiotic maintenance. 2, 3, 15 Moreover, the effectiveness of oral antibiotic therapy in the prevention of recurrent infection and associated late events remains undetermined. 3 The potential for the emergence of resistant strains or other unexpected infections following long-term oral antibiotics is another concern, 35,36 especially for elderly, debilitated, and immunocompromised patients. For patients with no evidence of active infection, we consider the administration of lifelong antibiotics to be unnecessary.
Our study is limited by its retrospective design and a relatively small number of cases. These two limitations are inherent to the study of primary infected aneurysms, as evidenced in other relevant reports. 1e5, 14, 17, 18, 21 However, this study consists of a large single-centre surgical cohort of infected abdominal aortic aneurysms with longitudinal follow-up. The operative details may help to distinguish the safeguards and pitfalls associated with in situ prosthetic replacement and to improve surgical outcomes for infected abdominal aortic aneurysms.
In conclusion, our experience with in situ reconstruction for patients without gastrointestinal involvement suggests that this technique can be safe and durable for the majority of patients with primary infected abdominal aortic aneurysms. Nevertheless, extra caution is required when considering in situ prosthetic replacement with concomitant gastrointestinal procedures.
